AstraZeneca will mark the second company to sign on to Trump's "most favored nation" drug pricing plan to lower prices in the U.S.
Trump to announce deal with AstraZeneca to lower drug costs
AstraZeneca will mark the second company to sign on to Trump's "most favored nation" drug pricing plan to lower prices in the U.S.